Australian collaborative trial of antenatal thyrotropin-releasing hormone (ACTOBAT) for prevention of neonatal respiratory disease

The addition of thyrotropin-releasing hormone (TRH) to antenatal glucocorticoid treatment of women at risk of preterm delivery has been reported to lower the risk of respiratory distress syndrome (RDS) in the infant. We have assessed the efficacy of 200 μg TRH in a multicentre randomised trial. 1234...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The Lancet (British edition) 1995-04, Vol.345 (8954), p.877-882
1. Verfasser:	CROWTHER, C. A
Format:	Artikel
Sprache:	eng
Schlagworte:	Adrenal Cortex Hormones - therapeutic use Apgar Score Australia Babies Biological and medical sciences Clinical trials Delivery. Postpartum. Lactation Disorders Female Gestational Age Gynecology. Andrology. Obstetrics Hormones Humans Infant, Newborn Infusions, Intravenous Maternal-Fetal Exchange Medical research Medical sciences Obstetric Labor, Premature - prevention & control Pregnancy Pregnancy, Multiple Respiratory diseases Respiratory Distress Syndrome, Newborn - prevention & control Respiratory Distress Syndrome, Newborn - therapy Thyrotropin-Releasing Hormone - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!